Hypoxia-Inducible Factor in Renal Cell Carcinoma: From Molecular Insights to Targeted Therapies
2024 · Genes · 11 citations
https://doi.org/10.3390/genes16010006
I
Ismaela Anna Vascotto
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
7
Papers
23
Citations
2
h-index
1
i10-index
Ismaela Anna Vascotto is an academic researcher from Azienda Ospedaliero-Universitaria Careggi. The author has contributed to research in topics: Renal cell carcinoma treatment & Bladder and Urothelial Cancer Treatments & Cancer Immunotherapy and Biomarkers. The author has an h-index of 2, co-authored 6 publications.
Papers by this author
worksNeutrophil-to-Eosinophil Ratio Predicts the Efficacy of Avelumab in Patients With Advanced Urothelial Carcinoma Enrolled in the MALVA Study (Meet-URO 25)
2024 · Clinical Genitourinary Cancer · 9 citations
https://doi.org/10.1016/j.clgc.2024.102099
Evaluating perineural invasion severity in head and neck cutaneous squamous cell carcinomas to refine prognostic accuracy: A retrospective case-control study
2025 · EJC Skin Cancer · 1 citations
https://doi.org/10.1016/j.ejcskn.2025.100743
Overlapping Extremes: An Analysis of Avelumab Maintenance and Pembrolizumab in Advanced Urothelial Carcinoma
2025 · Oncology and Therapy · 0 citations
https://doi.org/10.1007/s40487-025-00387-7
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat